scholarly journals Benefits from Treatment and Control of Patients with Resistant Hypertension

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Michael Doumas ◽  
Vasilios Papademetriou ◽  
Stella Douma ◽  
Charles Faselis ◽  
Konstantinos Tsioufis ◽  
...  

Resistant hypertension is commonly found in everyday clinical practice. However, the risks of resistant hypertension, as well as the benefits of treatment and control of blood pressure in patients with resistant hypertension remain vaguely clarified. Data from small clinical studies and observational cohorts suggest that patients with resistant hypertension are at increased cardiovascular risk, while control of blood pressure offers substantial benefits. It has to be noted however that data from appropriate large randomized studies are missing, and resistant hypertension remains remarkably understudied. Resistant hypertension has attracted significant scientific interest lately, as new therapeutic modalities become available. The interventional management of resistant hypertension either by carotid baroreceptor stimulation or renal sympathetic denervation is currently under investigation with promising preliminary results. This review presents available evidence regarding the benefits of treatment and control of blood pressure in patients with resistant hypertension and offers a critical evaluation of existing data in this field.

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Vasilios Papademetriou ◽  
Michael Doumas ◽  
Charles Faselis ◽  
Constantinos Tsioufis ◽  
Stella Douma ◽  
...  

Interventional activation of the carotid baroreflex has been an appealing idea for the management of resistant hypertension for several decades, yet its clinical application remained elusive and a goal for the future. It is only recently that the profound understanding of the complex anatomy and pathophysiology of the circuit, combined with the accumulation of relevant experimental and clinical data both in animals and in humans, has allowed the development of a more effective and well-promising approach. Indeed, current data support a sustained over a transient reduction of blood pressure through the resetting of baroreceptors, and technical deficits have been minimized with a subsequent recession of adverse events. In addition, clinical outcomes from the application of a new implantable device (Rheos) that induces carotid baroreceptor stimulation point towards a safe and effective blood pressure reduction, but longer experience is needed before its integration in the everyday clinical practice. While accumulating evidence indicates that carotid baroreceptor stimulation exerts its benefits beyond blood pressure reduction, further research is necessary to assess the spectrum of beneficial effects and evaluate potential hazards, before the extraction of secure conclusions.


2014 ◽  
Vol 12 (1) ◽  
pp. 55-62 ◽  
Author(s):  
Costas Tsioufis ◽  
Kyriakos Dimitriadis ◽  
Costas Thomopoulos ◽  
Michalis Doumas ◽  
Vasilios Papademetriou ◽  
...  

2015 ◽  
Vol 33 (12) ◽  
pp. 2512-2518 ◽  
Author(s):  
Sebastian Ewen ◽  
Oliver Dörr ◽  
Christian Ukena ◽  
Dominik Linz ◽  
Bodo Cremers ◽  
...  

Hypertension ◽  
2011 ◽  
Vol 58 (4) ◽  
pp. 559-565 ◽  
Author(s):  
Adam Witkowski ◽  
Aleksander Prejbisz ◽  
Elżbieta Florczak ◽  
Jacek Kądziela ◽  
Paweł Śliwiński ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document